Northwestern Mutual study reveals younger Americans focus more on wealth building than life and disability insurance, highlighting a gap in risk protection awareness and advisor engagement.
CMS escalates Medicare Advantage audits targeting upcoding and overpayments; research shows benefits of closer heart failure patient monitoring to reduce rehospitalizations; federal probe into nursing home COVID policies; nursing home financial fraud uncovered.
Explore the implications of proposed Medicare and Medicaid funding cuts on older adults and underserved communities, highlighting the role of nursing leaders and the aging U.S. population's healthcare needs.
CMS expands Medicare Advantage audits from 2018-2024, intensifying compliance demands and financial scrutiny for major health insurers like UnitedHealth, CVS, and Humana.
CMS excludes obesity drugs from 2026 Medicare coverage, citing cost concerns; Eli Lilly criticizes the decision impacting obesity management treatments.
Louisiana Senate advances SB-28 to offer up to $10,000 tax credits for fortified roofs, aiming to reduce home insurance losses and stabilize rising premiums.
Texas is set to ban hemp-derived THC consumables like gummies and edibles, excluding non-intoxicating CBD and CBG products, amid market and regulatory concerns. The move impacts an $8 billion industry, reflecting ongoing challenges in hemp product oversight.
Blue Cross Blue Shield of Vermont faces financial challenges leading to proposed rate hikes. Vermont regulators balance insurer solvency with affordability in ongoing insurance market discussions.
FDA refocuses COVID vaccine approvals on high-risk groups with new evidence requirements. Medicare fraud case results in sentencing for $3.2M scheme. Lower-income countries increase self-funded vaccine investments. Bipartisan prior authorization reform bill returns in Congress.
Ceresti Health opens a Medicare GUIDE wait list enabling family caregivers nationwide to access tech-enabled dementia care under CMS's new Medicare program launching July 2025. No cost to patients or caregivers.
